The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. After-hours trades for Idexx Laboratories, Inc. (IDXX) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.54, or 0.12%, to $461.10. The Idexx Laboratories, Inc. has recorded 32,940 volume in the after hours trading session. Yahoo Finance discussed the stock recently as it posted IDEXX Expands SNAP Platform with Leish 4Dx Test to Support Veterinarians Globally in Diagnosing Vector-borne Diseases.
Idexx Laboratories, Inc. is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Diagnostics & Research industry. At the end of the last regular session, the stock closed at $460.56 and fluctuated between $466.19 as its day high and $454.69 as its day low. The current market capitalization of Idexx Laboratories, Inc. is $38.25B. A total of 0.5 million shares were traded on the day, compared to an average of 477.99K shares.
Additionally, investors take into account insider trades when predicting how a stock will perform. During the recent three months, IDXX has seen 9 BUY and 11 SELL insider trades, representing the acquisition of 178,192 and the disposition of 185,659 shares. Over the last 12 months, there were 77 BUYs and 65 SELLs from insiders. Insiders purchased 250,354 shares during that period but sold 284,416.
In the most recent transaction, MAZELSKY JONATHAN JAY sold 13,424 shares of IDXX for 512.01 per share on Aug 31. After the transaction, the President and CEO now owns 72,925 company shares. In a previous transaction on Aug 29, POLEWACZYK JAMES F sold 22,909 shares at 510.56 per share. IDXX shares that Executive Vice President owns now total 10,038.
Among the insiders who sold shares, Lane Michael disposed of 16,027 shares on Aug 03 at a per-share price of $510.00. This resulted in the Executive Vice President holding 4,034 shares of IDXX after the transaction. In another insider transaction, AYERS JONATHAN W sold 10,000 shares at $491.35 per share on May 19. Company shares held by the Director now total 137,039.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. According to analysts who have offered 12-month price targets for IDXX in the last 3 months, the mean price target is $523.46 with high estimates of $600.00 and low estimates of $440.00. In terms of 52-week highs and lows, IDXX has a high of $564.73 and a low of $372.50.
As of this writing, IDXX has an earnings estimate of $2.1 per share for the current quarter. EPS was calculated based on a consensus of 8 estimates, with a high estimate of $2.14 per share and a lower estimate of $2.08. The company reported an EPS of $2.67 in the last quarter, which was 8.10% higher than expectations of $2.47.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. IDXX’s latest balance sheet shows that the firm has $144.45M in Cash & Short Term Investments as of fiscal 2021. There were $923.70M in debt and $763.58M in liabilities at the time. Its Book Value Per Share was $15.62, while its Total Shareholder’s Equity was $689.99M.
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for IDXX is Buy with a score of 4.13.